Association of Timing of Plasma Transfusion With Adverse Maternal Outcomes in Women With Persistent Postpartum Hemorrhage
Open Access
- 1 November 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 2 (11) , e1915628
Abstract
Obstetric hemorrhage accounts for 27% of all maternal deaths.1 In high-resource settings, maternal death due to postpartum hemorrhage (PPH) has become uncommon, but PPH remains an important cause of severe maternal morbidity.2-7Keywords
This publication has 58 references indexed in Scilit:
- An Observational Study of the Fresh Frozen PlasmaAnesthesia & Analgesia, 2013
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and HemodilutionAnesthesiology, 2010
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Obstetric intensive care unit admission: a 2-year nationwide population-based cohort studyIntensive Care Medicine, 2009
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Trends in adverse maternal outcomes during childbirth: a population-based study of severe maternal morbidityBMC Pregnancy and Childbirth, 2009
- How we treat: management of life‐threatening primary postpartum hemorrhage with a standardized massive transfusion protocolTransfusion, 2007
- Multiple imputation in health‐are databases: An overview and some applicationsStatistics in Medicine, 1991